Literature DB >> 12709015

Targeting dendritic cells with CD44 monoclonal antibodies selectively inhibits the proliferation of naive CD4+ T-helper cells by induction of FAS-independent T-cell apoptosis.

Christian Termeer1, Marco Averbeck, Hisamichi Hara, Herrmann Eibel, Peter Herrlich, Jonathan Sleeman, Jan C Simon.   

Abstract

CD44 is a multifunctional adhesion molecule that has been shown to be a costimulatory factor for T-cell activation in vitro and in vivo. The aim of the present study was to expand these findings by characterizing the role of CD44 during dendritic cell (DC) antigen presentation to naive, resting T cells. Certain monoclonal antibodies (mAbs) directed against all CD44 isoforms (pan CD44), or against the epitope encoded by the alternatively spliced exon v4 (CD44v4), dose-dependently inhibited the capacity of murine DC to induce proliferation of naive alloreactive T cells. Preincubation of the T cells or DC with these CD44 mAbs revealed that the effect was dependent upon mAb binding to DC, but not to T cells. DC treated with anti-pan CD44 and anti-CD44v4 mAbs induced CD4+ T-cell apoptosis, as shown by annexin V staining and TdT-mediated biotin-dUTP nick-end labelling (TUNEL) assays. However, CD4+ T-cell apoptosis was not dependent on the Fas/Fas ligand (Fas/FasL) system, as DC from FasL-deficient (Gld) mice and T cells from Fas-deficient (Lpr) mice were still susceptible to apoptosis induced by CD44-treated DC. To investigate whether CD44 treatment of DC affects early T-cell/DC interactions, time-lapse video microscopy was performed using peptide-specific T cells from T-cell receptor (TCR) transgenic mice. Interestingly, calcium signalling in CD4+ T cells was significantly diminished following interaction with CD44 mAb-treated DC, but this was not observed in CD8+ T cells. Taken together, we found that perturbation of distinct epitopes of CD44 on DC interfere with early Ca2+ signalling events during the activation of CD4+ T cells, resulting in T-cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12709015      PMCID: PMC1782945          DOI: 10.1046/j.1365-2567.2003.01617.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

1.  CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets.

Authors:  U Protin; T Schweighoffer; W Jochum; F Hilberg
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

2.  Modulation of superantigen-induced T-cell deletion by antibody anti-Pgp-1 (CD44).

Authors:  E Ayroldi; L Cannarile; C Ricardi
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

3.  Identification of a costimulatory molecule rapidly induced by CD40L as CD44H.

Authors:  Y Guo; Y Wu; S Shinde; M S Sy; A Aruffo; Y Liu
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

4.  Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation.

Authors:  L Lu; S Qian; P A Hershberger; W A Rudert; D H Lynch; A W Thomson
Journal:  J Immunol       Date:  1997-06-15       Impact factor: 5.422

5.  Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells.

Authors:  E Galluzzo; N Albi; S Fiorucci; C Merigiola; L Ruggeri; A Tosti; C E Grossi; A Velardi
Journal:  Eur J Immunol       Date:  1995-10       Impact factor: 5.532

6.  Signaling through CD44 is mediated by tyrosine kinases. Association with p56lck in T lymphocytes.

Authors:  T E Taher; L Smit; A W Griffioen; E J Schilder-Tol; J Borst; S T Pals
Journal:  J Biol Chem       Date:  1996-02-02       Impact factor: 5.157

7.  An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function.

Authors:  J M Weiss; J Sleeman; A C Renkl; H Dittmar; C C Termeer; S Taxis; N Howells; M Hofmann; G Köhler; E Schöpf; H Ponta; P Herrlich; J C Simon
Journal:  J Cell Biol       Date:  1997-06-02       Impact factor: 10.539

8.  CD44 (Pgp-1) inhibits CD3 and dexamethasone-induced apoptosis.

Authors:  E Ayroldi; L Cannarile; G Migliorati; A Bartoli; I Nicoletti; C Riccardi
Journal:  Blood       Date:  1995-10-01       Impact factor: 22.113

9.  Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis.

Authors:  K Mikecz; F R Brennan; J H Kim; T T Glant
Journal:  Nat Med       Date:  1995-06       Impact factor: 53.440

10.  A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V.

Authors:  I Vermes; C Haanen; H Steffens-Nakken; C Reutelingsperger
Journal:  J Immunol Methods       Date:  1995-07-17       Impact factor: 2.303

View more
  14 in total

Review 1.  The CD44-HA axis and inflammation in atherosclerosis: A temporal perspective.

Authors:  Mia Krolikoski; James Monslow; Ellen Puré
Journal:  Matrix Biol       Date:  2018-05-21       Impact factor: 11.583

2.  CD44 mobilization in allogeneic dendritic cell-T cell immunological synapse plays a key role in T cell activation.

Authors:  Venkatesh L Hegde; Narendra P Singh; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Leukoc Biol       Date:  2008-04-03       Impact factor: 4.962

3.  Maternal Milk T Cells Drive Development of Transgenerational Th1 Immunity in Offspring Thymus.

Authors:  Mrinal K Ghosh; Virginia Nguyen; H Konrad Muller; Ameae M Walker
Journal:  J Immunol       Date:  2016-08-05       Impact factor: 5.422

4.  Phenotype and polarization of autologous T cells by biomaterial-treated dendritic cells.

Authors:  Jaehyung Park; Michael H Gerber; Julia E Babensee
Journal:  J Biomed Mater Res A       Date:  2014-03-25       Impact factor: 4.396

5.  Enhanced expression of CD44 variants in human atheroma and abdominal aortic aneurysm: possible role for a feedback loop in endothelial cells.

Authors:  Alexandra Krettek; Galina K Sukhova; Uwe Schönbeck; Peter Libby
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

6.  Short-term treatment with anti-CD44v7 antibody, but not CD44v4, restores the gut mucosa in established chronic dextran sulphate sodium (DSS)-induced colitis in mice.

Authors:  S Farkas; M Hornung; C Sattler; M Anthuber; U Gunthert; H Herfarth; H J Schlitt; E K Geissler; B M Wittig
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

Review 7.  CD44 in cancer progression: adhesion, migration and growth regulation.

Authors:  R Marhaba; M Zöller
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

8.  Repeated social defeat activates dendritic cells and enhances Toll-like receptor dependent cytokine secretion.

Authors:  Nicole D Powell; M T Bailey; J W Mays; L M Stiner-Jones; M L Hanke; D A Padgett; John F Sheridan
Journal:  Brain Behav Immun       Date:  2008-09-26       Impact factor: 7.217

Review 9.  CD44 as a potential diagnostic tumor marker.

Authors:  Nawwaf S Basakran
Journal:  Saudi Med J       Date:  2015-03       Impact factor: 1.484

10.  Activated innate lymphoid cell populations accumulate in human tumour tissues.

Authors:  Maryam Salimi; Ruozheng Wang; Xuan Yao; Xi Li; Xiyan Wang; Yuhui Hu; Xumei Chang; Peiwen Fan; Tao Dong; Graham Ogg
Journal:  BMC Cancer       Date:  2018-03-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.